Cargando…

Immunohistochemical Profile for Unknown Primary Adenocarcinoma

BACKGROUND: Development of tailored treatment based on immunohistochemical profiles (IPs) of tumors for cancers of unknown primary is needed. METHODOLOGY/PRINCIPAL FINDINGS: We developed an algorithm based on primary known adenocarcinoma for testing sensitivity and specificity. Formalin-fixed paraff...

Descripción completa

Detalles Bibliográficos
Autores principales:	Hashimoto, Kenji, Sasajima, Yuko, Ando, Masashi, Yonemori, Kan, Hirakawa, Akihiro, Furuta, Koh, Tsuda, Hitoshi, Fujiwara, Yasuhiro
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Public Library of Science 2012
Materias:	Research Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3267772/ https://www.ncbi.nlm.nih.gov/pubmed/22299055 http://dx.doi.org/10.1371/journal.pone.0031181

Ejemplares similares

Primary Yolk Sac Tumor of the Omentum: A Case Report and Literature Review
por: Harano, Kenichi, et al.
Publicado: (2012)

Content Analysis of Oncology-Related Pharmaceutical Advertising in a Peer-Reviewed Medical Journal
por: Yonemori, Kan, et al.
Publicado: (2012)

Irinotecan plus carboplatin for patients with carcinoma of unknown primary site
por: Yonemori, K, et al.
Publicado: (2009)

The Incidence of Nonmalignant Diseases among Patients with Suspected Carcinoma of Unknown Primary Site
por: Sato, Jun, et al.
Publicado: (2019)

Use of Cox's Cure Model to Establish Clinical Determinants of Long-Term Disease-Free Survival in Neoadjuvant-Chemotherapy-Treated Breast Cancer Patients without Pathologic Complete Response
por: Asano, Junichi, et al.
Publicado: (2013)

Pathological features of triple‐negative breast cancers that showed progressive disease during neoadjuvant chemotherapy
por: Tanabe, Yuko, et al.
Publicado: (2017)

Drug induced interstitial lung disease in oncology phase I trials
por: Yonemori, Kan, et al.
Publicado: (2016)

Prognostic impact of presumed breast or ovarian cancer among patients with unfavorable-subset cancer of unknown primary site
por: Kodaira, Makoto, et al.
Publicado: (2018)

Racial differences in longitudinal toxicities of anticancer agents in early phase cancer clinical trials
por: Mizusawa, Junki, et al.
Publicado: (2023)

Potential utility of a longitudinal relative dose intensity of molecularly targeted agents in phase 1 dose‐finding trials
por: Hirakawa, Akihiro, et al.
Publicado: (2017)

First-line treatment for lung cancer among Japanese older patients: A real-world analysis of hospital-based cancer registry data
por: Noda-Narita, Shoko, et al.
Publicado: (2021)

Immunohistochemical profiles of claudin-3 in primary and metastatic prostatic adenocarcinoma
por: Bartholow, Tanner L, et al.
Publicado: (2011)

Adenocarcinoma of Unknown Primary Site
por: Song, Seo Young, et al.
Publicado: (2002)

Change in the hormone receptor status following administration of neoadjuvant chemotherapy and its impact on the long-term outcome in patients with primary breast cancer
por: Hirata, T, et al.
Publicado: (2009)

Tumour-infiltrating lymphocytes are correlated with higher expression levels of PD-1 and PD-L1 in early breast cancer
por: Kitano, Atsuko, et al.
Publicado: (2017)

Phase I and pharmacokinetic study of trabectedin, a DNA minor groove binder, administered as a 24-h continuous infusion in Japanese patients with soft tissue sarcoma
por: Ueda, Takafumi, et al.
Publicado: (2014)

Hotspot mutation profiles of AKT1 in Asian women with breast and endometrial cancers
por: Shimoi, Tatsunori, et al.
Publicado: (2021)

MASTER KEY Project: Powering Clinical Development for Rare Cancers Through a Platform Trial
por: Okuma, Hitomi S., et al.
Publicado: (2020)

Radical hysterectomy for FIGO stage I–IIB adenocarcinoma of the uterine cervix
por: Kasamatsu, T, et al.
Publicado: (2009)

HER2 Oncogene Amplification and Immunohistochemical Profiling in Gastric Adenocarcinoma
por: Raj, Nisha, et al.
Publicado: (2018)

Therapeutic target biomarkers of patient-derived xenograft models of gastric-type cervical adenocarcinoma
por: Kojima, Yuki, et al.
Publicado: (2023)

Taxane-induced sensory peripheral neuropathy is associated with an SCN9A single nucleotide polymorphism in Japanese patients
por: Tanabe, Yuko, et al.
Publicado: (2020)

Visualization of the distribution of nanoparticle-formulated AZD2811 in mouse tumor model using matrix-assisted laser desorption ionization mass spectrometry imaging
por: Ryu, Shoraku, et al.
Publicado: (2020)

Gingival metastasis of adenocarcinoma with an unknown occult primary
por: Naik, Rashmi, et al.
Publicado: (2019)

Non-suppurative Meningoencephalitis of Unknown Origin in Cats and Dogs: an Immunohistochemical Study
por: Schwab, S., et al.
Publicado: (2007)

Neuroendocrine Tumor of Unknown Primary Accompanied with Stomach Adenocarcinoma
por: Kim, Ho-Yeun, et al.
Publicado: (2011)

Adenocarcinoma of an Unknown Primary Site: Presentation, Diagnosis, and Management
por: Abou-Ghaida, Jaafar, et al.
Publicado: (2023)

Efficacy of capecitabine in patients with locally advanced or metastatic breast cancer with or without prior treatment with fluoropyrimidine: a retrospective study
por: Iizumi, Sakura, et al.
Publicado: (2018)

Transcriptomic and Immunohistochemical Profiling of SLC6A14 in Pancreatic Ductal Adenocarcinoma
por: Penheiter, Alan R., et al.
Publicado: (2015)

Clinical Utility of Circulating Tumor DNA in Advanced Rare Cancers
por: Okuma, Hitomi Sumiyoshi, et al.
Publicado: (2021)

Primary adenocarcinoma of the thymus: an immunohistochemical and molecular study with review of the literature
por: Maghbool, Maryam, et al.
Publicado: (2013)

Adenocarcinoma arising from widespread heterotopic gastric mucosa in the cervicothoracic esophagus: a case report
por: Nogi, Shohei, et al.
Publicado: (2023)

Comprehensive analysis of cancer of unknown primary and recommendation of a histological and immunohistochemical diagnostic strategy from China
por: Ren, Min, et al.
Publicado: (2023)

Cutaneous metastasis from gastrointestinal adenocarcinoma of unknown primary origin
por: Junqueira, Ana Lucia Ariano, et al.
Publicado: (2015)

Atypical Presentation of Prostate Cancer and the Workup of an Adenocarcinoma of Unknown Primary
por: Ahmad, Asim, et al.
Publicado: (2012)

Response to Dabrafenib and Trametinib of a Patient with Metaplastic Breast Carcinoma Harboring a BRAF V600E Mutation
por: Seo, Takuji, et al.
Publicado: (2020)

Mesonephric-like Adenocarcinoma of the Uterine Corpus: Genomic and Immunohistochemical Profiling with Comprehensive Clinicopathological Analysis of 17 Consecutive Cases from a Single Institution
por: Koh, Hyun-Hee, et al.
Publicado: (2023)

Granulocyte Colony-Stimulating Factor-Producing Carcinoma of Unknown Primary Site
por: Yasui, Hirotoshi, et al.
Publicado: (2014)

Immunohistochemical study of hepatocyte, cholangiocyte and stem cell markers of hepatocellular carcinoma: the second report: relationship with tumor size and cell differentiation
por: Kumagai, Arisa, et al.
Publicado: (2016)

An immune-related gene expression signature predicts brain metastasis in lung adenocarcinoma patients after surgery: gene expression profile and immunohistochemical analyses
por: Koh, Young Wha, et al.
Publicado: (2021)

Cannot write session to /tmp/vufind_sessions/sess_2iv4j3ounhhcjj3ibnnt90qeu4